Theratechnologies Future Growth
Future criteria checks 1/6
Theratechnologies is forecast to grow earnings and revenue by 22.9% and 15.4% per annum respectively while EPS is expected to grow by 62.4% per annum.
Key information
22.9%
Earnings growth rate
62.4%
EPS growth rate
| Biotechs earnings growth | 37.1% |
| Revenue growth rate | 15.4% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 10 Apr 2024 |
Recent future growth updates
Recent updates
Increases to CEO Compensation Might Be Put On Hold For Now at Theratechnologies Inc. (TSE:TH)
May 03
Theratechnologies Inc.'s (TSE:TH) Share Price Boosted 25% But Its Business Prospects Need A Lift Too
Apr 10Earnings Update: Theratechnologies Inc. (TSE:TH) Just Reported And Analysts Are Trimming Their Forecasts
Feb 24Investors Don't See Light At End Of Theratechnologies Inc.'s (TSE:TH) Tunnel And Push Stock Down 27%
Feb 07The Market Doesn't Like What It Sees From Theratechnologies Inc.'s (TSE:TH) Revenues Yet
Apr 17Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 11/30/2026 | 107 | -14 | 25 | 22 | 5 |
| 11/30/2025 | 95 | -10 | 12 | 7 | 5 |
| 11/30/2024 | 88 | -7 | 5 | -2 | 5 |
| 2/29/2024 | 78 | -18 | -6 | -4 | N/A |
| 11/30/2023 | 82 | -24 | -7 | -6 | N/A |
| 8/31/2023 | 80 | -29 | -7 | -7 | N/A |
| 5/31/2023 | 80 | -36 | -16 | -15 | N/A |
| 2/28/2023 | 81 | -49 | -14 | -12 | N/A |
| 11/30/2022 | 80 | -47 | -16 | -15 | N/A |
| 8/31/2022 | 77 | -49 | -19 | -18 | N/A |
| 5/31/2022 | 74 | -51 | -19 | -18 | N/A |
| 2/28/2022 | 73 | -35 | -18 | -18 | N/A |
| 11/30/2021 | 70 | -32 | -18 | -18 | N/A |
| 8/31/2021 | 70 | -27 | -15 | -15 | N/A |
| 5/31/2021 | 66 | -25 | -12 | -12 | N/A |
| 2/28/2021 | 66 | -24 | -14 | -14 | N/A |
| 11/30/2020 | 66 | -23 | -14 | -14 | N/A |
| 8/31/2020 | 63 | -24 | -11 | -10 | N/A |
| 5/31/2020 | 65 | -18 | -5 | -5 | N/A |
| 2/29/2020 | 64 | -16 | -13 | -12 | N/A |
| 11/30/2019 | 63 | -12 | -7 | -3 | N/A |
| 8/31/2019 | 61 | -7 | -21 | 2 | N/A |
| 5/31/2019 | 58 | -5 | -26 | -3 | N/A |
| 2/28/2019 | 52 | -4 | -18 | 4 | N/A |
| 11/30/2018 | 45 | -5 | -19 | 0 | N/A |
| 8/31/2018 | 41 | -7 | -1 | -1 | N/A |
| 5/31/2018 | 36 | -9 | -3 | -3 | N/A |
| 2/28/2018 | 35 | -15 | 0 | 0 | N/A |
| 11/30/2017 | 33 | -14 | N/A | 2 | N/A |
| 8/31/2017 | 33 | -11 | N/A | 3 | N/A |
| 5/31/2017 | 28 | -8 | N/A | 3 | N/A |
| 2/28/2017 | 28 | -1 | N/A | 4 | N/A |
| 11/30/2016 | 28 | 0 | N/A | 2 | N/A |
| 8/31/2016 | 27 | 1 | N/A | 2 | N/A |
| 5/31/2016 | 27 | 1 | N/A | 4 | N/A |
| 2/29/2016 | 25 | 2 | N/A | 5 | N/A |
| 11/30/2015 | 23 | 1 | N/A | 5 | N/A |
| 8/31/2015 | 18 | -2 | N/A | 1 | N/A |
| 5/31/2015 | 12 | -6 | N/A | 0 | N/A |
| 2/28/2015 | 8 | -6 | N/A | -4 | N/A |
| 11/30/2014 | 6 | -9 | N/A | -7 | N/A |
| 8/31/2014 | 5 | -9 | N/A | -6 | N/A |
| 5/31/2014 | 7 | -7 | N/A | -6 | N/A |
| 2/28/2014 | 7 | -9 | N/A | -6 | N/A |
| 11/30/2013 | 7 | -4 | N/A | -7 | N/A |
| 8/31/2013 | 10 | -5 | N/A | -10 | N/A |
| 5/31/2013 | 11 | -4 | N/A | -10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: TH's revenue (15.4% per year) is forecast to grow faster than the Canadian market (6.6% per year).
High Growth Revenue: TH's revenue (15.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TH's Return on Equity is forecast to be high in 3 years time